LAMBDA CLIMATE RESEARCH LTD
Company number 13659766 · Monitor this company
This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.
LAMBDA CLIMATE RESEARCH LTD - Analysis Report
Company Number: 13659766
Analysis Date: 2025-07-20 17:57 UTC
Financial Health Assessment: LAMBDA CLIMATE RESEARCH LTD (As of 31 October 2024)
1. Financial Health Score: B
Explanation:
The company exhibits a solid improvement in its financial position over the last year, with net current assets and net assets increasing substantially. This signals a company with a healthy liquidity position and strengthening equity base. However, the absence of fixed assets and relatively modest scale of operations (micro-entity) limits the grade from reaching an "A". Overall, the financial vital signs suggest a stable and growing business with a good cash cushion.
2. Key Vital Signs:
| Metric | 2024 (£) | 2023 (£) | Interpretation |
|---|---|---|---|
| Fixed Assets | 0 | 196 | No long-term assets held currently; typical for a research consultancy operating with minimal capital investment. |
| Current Assets | 56,673 | 20,190 | Healthy increase in liquid assets such as cash or receivables, indicating improved cash inflow or funding. |
| Current Liabilities | 27,406 | 18,183 | Increase in short-term obligations, but well covered by current assets. |
| Net Current Assets (Working Capital) | 29,267 | 2,007 | Strong positive working capital, showing ample short-term liquidity to meet commitments. |
| Net Assets (Equity) | 29,267 | 2,203 | Significant growth in shareholder funds, indicating retained earnings or capital infusion. |
| Average Number of Employees | 2 | 2 | Small team, consistent with micro-entity classification. |
Interpretation of Vital Signs:
- The company's cash and receivables have nearly tripled, a sign of improved cash flow or successful capital raising—akin to a patient who has regained strength after a period of weakness.
- Current liabilities have risen but remain comfortably covered by current assets, indicating no immediate liquidity distress.
- Net equity has increased more than tenfold, reflecting an accumulation of resources or possible capital injections, underpinning financial stability.
- The lack of fixed assets suggests the company’s business is knowledge-based rather than asset-heavy, common in research and consultancy sectors.
3. Diagnosis:
Underlying Financial Health:
The company is displaying strong signs of financial wellness. The sharp increase in net current assets and net equity over the last year points to successful business operations or capital funding. The working capital buffer acts like a healthy heartbeat, ensuring obligations can be met promptly without strain.
Symptoms of Distress:
Currently, there are no visible symptoms such as negative working capital, declining equity, or overdue filings. The company is up to date with statutory filings, indicating good compliance and governance.
Business Model Insight:
As a micro-entity operating in environmental consulting and natural sciences research, the heavy reliance on current assets and minimal fixed assets is normal. The business appears to be well-capitalized for its scale, with a stable director/owner structure and no signs of financial fatigue.
4. Recommendations:
- Maintain Cash Flow Vigilance: Continue monitoring liquidity closely to sustain the healthy cash position, ensuring that receivables are collected promptly and liabilities managed efficiently.
- Consider Asset Investment: Explore opportunities for strategic investment in fixed assets or intellectual property that could enhance long-term value and competitive edge.
- Strengthen Revenue Streams: Given the growth in assets, focus on scaling operations sustainably to convert this financial strength into increased profitability and market presence.
- Governance and Compliance: Keep filings timely and maintain transparent reporting to uphold stakeholder confidence and avoid penalties.
- Risk Management: Implement a contingency plan for potential market or funding shocks, ensuring the company’s robust financial "immune system" can respond effectively.
Sign in to generate a free AI analysis of this company — no password needed, just an email link.